If your level is in the range of 3.0-3.4 mmol/L, you have mild hypokalemia, and if your level is lower than 3 mmol/L, you have moderate hypokalemia
Healthcare professionals may recommend dietary changes, oral supplements or vitamin B12 injections where clinically appropriate
Priority research needs include large-scale randomized controlled trials to establish efficacy and safety, dose-ranging studies to optimize treatment protocols, long-term safety studies particularly regarding cancer risk, and comparative effectiveness research with established therapies
In one human trial, 7 of 12 patients with chronic knee pain experienced relief for more than six months following BPC-157 injections ( PMC 12313605 )
routine use in replete patients has limited evidence
Additionally, they have been recognized for their outstanding business practices